CN111135344A - Scaffold for repairing carbon nano tube/collagen-based cartilage of composite albumin and preparation method thereof - Google Patents

Scaffold for repairing carbon nano tube/collagen-based cartilage of composite albumin and preparation method thereof Download PDF

Info

Publication number
CN111135344A
CN111135344A CN202010125955.5A CN202010125955A CN111135344A CN 111135344 A CN111135344 A CN 111135344A CN 202010125955 A CN202010125955 A CN 202010125955A CN 111135344 A CN111135344 A CN 111135344A
Authority
CN
China
Prior art keywords
collagen
scaffold
albumin
repairing
cartilage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010125955.5A
Other languages
Chinese (zh)
Inventor
王建华
黄晨光
陈杨燕
丁自凤
陈立
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuzhou University
Original Assignee
Fuzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuzhou University filed Critical Fuzhou University
Priority to CN202010125955.5A priority Critical patent/CN111135344A/en
Publication of CN111135344A publication Critical patent/CN111135344A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/08Carbon ; Graphite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/06Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Abstract

The invention discloses a composite albumin carbon nanotube/collagen-based cartilage repair scaffold for articular cartilage defect repair and a preparation method thereof. The repair scaffold is prepared by using carboxyl functionalized single-walled carbon nanotubes, albumin powder and freeze-dried collagen as main raw materials. After the repairing scaffold is implanted into an animal model with articular cartilage defect for 12 weeks, the repairing scaffold can better repair the articular cartilage defect, wherein the repairing effect of the repairing scaffold containing 0.5 wt% of carbon nano tubes is the best. The cartilage repairing scaffold prepared by the invention has the characteristics of good mechanical property, biocompatibility, biodegradability and the like, has a good repairing effect on articular cartilage defects, and is a good tissue regeneration material which can be popularized and used in cartilage tissue engineering.

Description

Scaffold for repairing carbon nano tube/collagen-based cartilage of composite albumin and preparation method thereof
Technical Field
The invention belongs to the field of biomedicine, and particularly relates to a carbon nanotube/collagen-based cartilage repair scaffold compounded with albumin and a preparation method thereof.
Background
Articular cartilage is a very complex hyaline-like cartilage connective tissue that plays a major role in weight bearing and movement in joint activity. Since the cartilage tissue has no blood vessels, lymphatic vessels and nervous tissues, the nutrition is mainly absorbed by synovial fluid secreted by synovium, synovial blood vessel osmosis and diffusion mode. When cartilage is damaged, the condition of the damaged part is gradually worsened due to the lack of blood supply and limited nutrient absorption, so that the cartilage is extremely difficult to repair by itself after being damaged. At present, the clinical methods for repairing the articular cartilage mainly comprise: subchondral bone microarthrosis, autologous chondrocyte transplantation, allogeneic cartilage transplantation, and the like, but the above methods are not satisfactory in practice, and therefore, tissue engineering has rapidly grown in recent years. In cartilage tissue engineering, the scaffold material serves as a carrier for growth of chondrocytes and plays a decisive role in growth of the chondrocytes, so that research on repair materials is very important. For the repair materials currently under development, poor mechanical properties are one of the main disadvantages of such materials.
Carbon nanotubes are cylindrical graphite tubes having a large aspect ratio, and are often classified into single-walled carbon nanotubes and multi-walled carbon nanotubes according to their tube wall structures, which have received wide attention in various fields such as medicine, tissue engineering, drug administration, etc. due to their unique chemical, mechanical, electrical conductivity and low toxicity. However, a large number of studies have confirmed that carbon nanotubes may have potential cytotoxicity, and have not been found to be used in vivo studies for cartilage defect repair in the field of cartilage repair. Therefore, there is a need for animal or organism in vivo studies on carbon nanotube-containing repair materials.
Serum albumin is the earliest and clearest component in plasma research, and has the advantages of safety, no toxicity, biodegradability, good biocompatibility and the like. The combination of serum albumin and multi-wall carbon nano-tubes can reduce the potential toxic effect of the multi-wall carbon nano-tubes, but the effect on the single-wall carbon nano-tubes is not reported. Collagen, which accounts for 50-80% of the articular cartilage, is a main component of the articular cartilage, has the advantages of good biocompatibility, degradability, low immunogenicity and the like, and has been widely used for the preparation of tissue regeneration materials.
The invention synthesizes the carbon nano tube to effectively improve the mechanical property of the material, the potential cytotoxicity of the single-walled carbon nano tube can be counteracted by the combined serum albumin, and the composite albumin-carbon nano tube/collagen-based cartilage repair bracket which can effectively repair cartilage defect is prepared by cooperating with the excellent performance of natural collagen.
Disclosure of Invention
The invention aims to provide a scaffold for repairing a carbon nano tube/collagen-based cartilage, which is compounded with albumin, has good mechanical strength and biological performance, and shows a good repairing effect in the in-vivo repair of cartilage defects.
In order to achieve the purpose, the invention adopts the following technical scheme:
the scaffold for repairing the carbon nanotube/collagen-based cartilage of the composite albumin is prepared by taking a carboxyl functionalized single-walled carbon nanotube, albumin powder and freeze-dried collagen as main raw materials, wherein the mass ratio of the carboxyl functionalized single-walled carbon nanotube to the albumin powder to the freeze-dried collagen is (0-4): 4: 200. the freeze-dried collagen is derived from fish skin, pig skin, cow skin or beef tendon.
The preparation method of the albumin-compounded carbon nanotube/collagen-based cartilage repair scaffold comprises the following steps:
(1) dissolving the freeze-dried collagen in water to prepare a collagen solution;
(2) dissolving albumin powder in ultrapure water to prepare a protein water solution;
(3) adding the carboxyl functionalized single-walled carbon nanotubes into the protein aqueous solution obtained in the step (2), and performing ultrasonic treatment to uniformly disperse the carboxyl functionalized single-walled carbon nanotubes;
(4) mixing the uniformly dispersed solution obtained in the step (3) with the collagen solution obtained in the step (1), and stirring overnight by magnetic force;
(5) after freeze-drying, adding a cross-linking agent according to 350 mL/g for cross-linking; the cross-linking agent is prepared by dissolving 1-ethyl-3 (3-dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide in ethanol solution with volume concentration of 95% according to the amount of 50 mmol/L and 8 mmol/L respectively and mixing;
(6) repeatedly soaking in distilled water after crosslinking until cleaning, and lyophilizing again; soaking with distilled water for 30min, and repeating soaking for 6 times.
The invention has the following beneficial effects:
1. the cartilage repair stent for treating articular cartilage defects, which is prepared by the invention, has the advantages of simple preparation process, low price, easy obtainment and mature process. The repair scaffold is of a three-dimensional net structure, the mechanical property of the carbon nanotube reinforced material is utilized, the potential toxicity of the carbon nanotube is counteracted by albumin, and an excellent cell microenvironment is provided for the repair material by utilizing collagen, so that the repair scaffold is an excellent repair material suitable for articular cartilage defect treatment.
2. Animal experiments prove that the repair scaffold prepared by the invention has good effect of repairing cartilage defect.
Drawings
Fig. 1 is a scanning electron microscope image of the albumin-complexed carbon nanotube/collagen-based cartilage repair scaffold obtained in example 3 at different magnifications (wherein black arrows indicate carbon nanotubes in the repair scaffold and gray arrows indicate collagen fibers in the repair scaffold).
FIG. 2 is a graph showing the compressive strength of the prosthetic stents obtained in examples 1-4.
FIG. 3 is a graph showing cytotoxicity tests of the scaffolds prepared in examples 1-4.
FIG. 4 is a comparison graph of toluidine blue staining of pathological specimen detection at 12 weeks for the repaired stent with carbon nanotube content of 0 (A), 0.5 wt% (B) and 2.0 wt% (C), respectively.
Detailed Description
In order to make the present invention more comprehensible, the technical solutions of the present invention are further described below with reference to specific embodiments, but the present invention is not limited thereto.
The preparation method of the carboxyl functionalized single-walled carbon nanotube comprises the following steps: firstly, preparing a single-walled carbon nanotube by adopting a chemical vapor deposition method, wherein the purity of the single-walled carbon nanotube is more than 95 wt%, the inner diameter of the single-walled carbon nanotube is 0.8-1.6 nm, and the outer diameter of the single-walled carbon nanotube is 1-2 nm; and then adding 120 mL of 2.6 mol/L dilute nitric acid into a single-neck round-bottom flask, adding 50 mg of the single-walled carbon nanotube, carrying out ultrasonic treatment for 30min, heating to a reflux state, stirring for 24 h, cooling after the reaction is finished, washing with ultrapure water to be neutral, collecting, and drying to obtain the purified carboxyl functionalized single-walled carbon nanotube.
The cross-linking agent is prepared by dissolving 5 mmol of 1-ethyl-3 (3-dimethylaminopropyl) carbodiimide and 0.8 mmol of N-hydroxysuccinimide in 100 mL of 95 volume percent ethanol solution and mixing.
Example 1
(1) Accurately weighing 0.2 g of bovine type I collagen freeze-dried powder, adding 15 mL of deionized water (containing 0.1% glacial acetic acid) into a magnetic stirrer, and uniformly stirring to obtain a collagen solution (O);
(2) accurately weighing 4mg of bovine serum albumin powder, dissolving the bovine serum albumin powder in 10 mL of ultrapure water, and placing the bovine serum albumin powder on a magnetic stirrer to be stirred and dissolved to prepare a bovine serum albumin solution with the concentration of 0.4 mg/mL;
(3) accurately weighing 2 mg of carboxyl functionalized single-walled carbon nanotubes, adding the carboxyl functionalized single-walled carbon nanotubes into the bovine serum albumin solution prepared in the step (2), and performing ultrasonic treatment for 30min (during which the solution is vibrated every 5 min) to disperse the carboxyl functionalized single-walled carbon nanotubes, thereby finally obtaining a suspension in which the carboxyl functionalized single-walled carbon nanotubes are uniformly dispersed;
(4) adding a collagen solution (O) into the suspension in which the carboxyl functionalized single-walled carbon nanotubes are uniformly dispersed, violently stirring for 30min, slowly stirring overnight, freeze-drying, taking out, and adding 70 mL of a cross-linking agent for cross-linking;
(5) and soaking the cross-linked scaffold in distilled water for 30min, repeating the soaking for 6 times, and freeze-drying again to obtain the repair scaffold with the carbon nanotube content of 1.0 wt%, which is marked as A.
Example 2
Replacing the using amount of the carboxyl functionalized single-walled carbon nanotube in the step (3) with 1 mg, and performing the other steps in the same way as in the example 1 to prepare a repair scaffold with the carbon nanotube content of 0.5 wt%, which is marked as B.
Example 3
Replacing the using amount of the carboxyl functionalized single-walled carbon nanotube in the step (3) with 4mg, and preparing the repairing scaffold with the carbon nanotube content of 2.0 wt% by the same steps as the example 1, wherein the repairing scaffold is marked as C.
Example 4
Replacing the using amount of the carboxyl functionalized single-walled carbon nanotube in the step (3) with 0 mg, and performing the other steps in the same manner as in the example 1 to obtain a repair scaffold without the carbon nanotube, which is marked as D.
1. And (3) testing mechanical properties:
the prosthetic scaffolds prepared in examples 1-4 were trimmed to cylinders 5 cm in diameter and 5 cm in height and tested for mechanical properties on a universal material testing machine, respectively, with an instrument chuck speed of 1 mm/min during the test. And taking the corresponding compressive stress when the deformation reaches 60% as the compressive modulus of the stent material, and taking the stress corresponding to the 60% deformation rate to calculate the compressive strength.
As can be seen from fig. 2, the compressive strength of the repair scaffold is increased with the addition of the carbon nanotubes, which proves that the addition of the carbon nanotubes has the effect of improving the mechanical properties of the repair scaffold.
2. Cytotoxicity test:
the prosthetic scaffolds prepared in examples 1-4 were added to DMEM/F-12 medium at 5 mg/mL (scaffold/medium) and extracted in an incubator at 37 ℃ for 48 h. And filtering the obtained leaching liquor by a 0.22 mu m filter membrane, and adding 10% FBS into the leaching liquor to obtain a sample solution to be detected corresponding to each repair bracket.
BMSCs at 1X 104Cell/well Density in 96-well plates at 37 ℃ with 5% CO2After culturing for 24 h, removing non-adherent cells from the pore plate, and adding the sample solution to be detected into the pores respectivelyIn the plate, the culture was continued, and the culture medium was changed every two days. Samples were taken on days 1, 3, 5, and 7 of the culture to measure the absorbance at 450 nm, and the results are shown in FIG. 3 (the plate to which no sample solution was added was used as a blank).
As can be seen from fig. 3, compared with the blank control, the cell viability of the sample solution with the repair scaffold added thereto is not significantly inhibited, and on day 7, each group shows a cell viability trend of D > B > a > C > control (the cell viability gradually decreases to a normal level with the increase of the content of the carbon nanotube), which proves that the addition amount of the carbon nanotube is within 2.0 wt% without cytotoxicity. Meanwhile, the comparison between D and control shows that the addition of the bovine serum albumin composite collagen-based material into cells is helpful for improving the cell viability.
3. Animal in vivo test:
operation: 24 clean-grade New Zealand rabbits were randomly divided by weight into 6 groups of 4, 8 joints per group. The grouping is as follows: model control group (group a): the defect part is not treated; defect group (group B): implanting the sterile repair scaffold prepared in example 1 into the defect; defect group (group C): implanting the sterile repair scaffold prepared in example 2 into the defect; defect group (group D): implanting the sterile repair scaffold prepared in example 3 into the defect; defect group (group E): implanting the sterile repair scaffold prepared in example 4 into the defect; blank control group (group F): normal group without defect. After grouping, anaesthetizing with fast-sleep new II (0.3 mL/kg) and constructing cartilage and subchondral bone defect models, wherein the diameter of a defect area is 4 mm, and the depth is about 4 mm.
According to the grouping, the repair stents sterilized by gamma rays are respectively implanted into the articular cartilage defect model, and the wounds are sutured layer by layer. Each rabbit was injected intramuscularly with 10 ten thousand units of penicillin sodium for 1 week after surgery to prevent infection.
Post-operative observation and specimen handling: at 12 weeks after surgery, groups of experimental animals were sacrificed by otolimbic intravenous injection of excess hypnotic neo-II, gross observation, HE staining, toluidine blue staining.
As a result: the albumin-compounded carbon nanotube/collagen-based cartilage repair scaffold has a good repair effect on articular cartilage defects, and when the content of the carbon nanotubes is 0.5 wt%, the repair effect is optimal (as shown in figure 4), and the boundary between the new cartilage tissue and the surrounding tissue is not obvious. With the increase of the content of the carbon nano tube, the mechanical property of the repair material is better improved, the transparent cartilage tissue can be still generated at the defect part, but the repair period is delayed because the degradation period of the repair scaffold is prolonged. Therefore, the albumin-compounded carbon nanotube/collagen-based cartilage repair scaffold for repairing articular cartilage defects of animals does not have the best effect when the content of the carbon nanotubes is higher and is 0.5 wt%.
The above description is only a preferred embodiment of the present invention, and all equivalent changes and modifications made in accordance with the claims of the present invention should be covered by the present invention.

Claims (5)

1. A scaffold for repairing carbon nano tube/collagen-based cartilage of composite albumin is characterized in that: the cartilage repair scaffold is prepared from carboxyl functionalized single-walled carbon nanotubes, albumin powder and freeze-dried collagen serving as main raw materials, wherein the mass ratio of the carboxyl functionalized single-walled carbon nanotubes to the albumin powder to the freeze-dried collagen is (0-4): 4: 200.
2. the scaffold for carbon nanotube/collagen-based cartilage repair of composite albumin according to claim 1, wherein: the freeze-dried collagen is derived from fish skin, pig skin, cow skin or beef tendon.
3. A method for preparing the albumin-complexed carbon nanotube/collagen-based cartilage repair scaffold according to claim 1, wherein the method comprises the following steps: the method comprises the following steps:
(1) dissolving the freeze-dried collagen in water to prepare a collagen solution;
(2) dissolving albumin powder in ultrapure water to prepare a protein water solution;
(3) adding the carboxyl functionalized single-walled carbon nanotubes into the protein aqueous solution obtained in the step (2), and performing ultrasonic treatment to uniformly disperse the carboxyl functionalized single-walled carbon nanotubes;
(4) mixing the uniformly dispersed solution obtained in the step (3) with the collagen solution obtained in the step (1), and stirring overnight by magnetic force;
(5) adding a cross-linking agent for cross-linking after freeze-drying;
(6) repeatedly soaking in distilled water after crosslinking, cleaning, and lyophilizing again.
4. The method for preparing the scaffold for repairing the carbon nanotube/collagen-based cartilage, which is compounded with albumin according to claim 3, wherein the method comprises the following steps: the cross-linking agent in the step (5) is prepared by dissolving and mixing 1-ethyl-3 (3-dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide in ethanol solution with volume concentration of 95% according to the amount of 50 mmol/L and 8 mmol/L respectively.
5. The method for preparing the scaffold for repairing the carbon nanotube/collagen-based cartilage, which is compounded with albumin according to claim 3, wherein the method comprises the following steps: in the step (6), the time for soaking once by using distilled water is 30min, and the repeated soaking times are 6 times.
CN202010125955.5A 2020-02-27 2020-02-27 Scaffold for repairing carbon nano tube/collagen-based cartilage of composite albumin and preparation method thereof Pending CN111135344A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010125955.5A CN111135344A (en) 2020-02-27 2020-02-27 Scaffold for repairing carbon nano tube/collagen-based cartilage of composite albumin and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010125955.5A CN111135344A (en) 2020-02-27 2020-02-27 Scaffold for repairing carbon nano tube/collagen-based cartilage of composite albumin and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111135344A true CN111135344A (en) 2020-05-12

Family

ID=70528151

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010125955.5A Pending CN111135344A (en) 2020-02-27 2020-02-27 Scaffold for repairing carbon nano tube/collagen-based cartilage of composite albumin and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111135344A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112778572A (en) * 2021-01-04 2021-05-11 常州大学 Collagen-based material capable of inhibiting new blood vessels and preparation method thereof
CN113244458A (en) * 2021-05-08 2021-08-13 康膝生物医疗(深圳)有限公司 Composite material for repairing articular cartilage damage and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101432227A (en) * 2004-06-23 2009-05-13 海珀里昂催化国际有限公司 Functionalized single walled carbon nanotubes
CN101693125A (en) * 2009-10-12 2010-04-14 北京科技大学 Process for preparing biocompatible directional carbon nanotube array reinforced composite hydrogel
CN102526806A (en) * 2012-01-20 2012-07-04 陕西博鸿生物科技有限公司 Tissue engineering cartilage and preparation method thereof
CN103007357A (en) * 2012-12-25 2013-04-03 福建省博特生物科技有限公司 Application of carbon nano tube/collagen based composite material
CN103013140A (en) * 2012-12-25 2013-04-03 福建省博特生物科技有限公司 Carbon nano tube/collagen based composite material and preparation method thereof
US9737632B2 (en) * 2013-09-25 2017-08-22 Nanofiber Solutions, Inc. Fiber scaffolds for use creating implantable structures

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101432227A (en) * 2004-06-23 2009-05-13 海珀里昂催化国际有限公司 Functionalized single walled carbon nanotubes
CN101693125A (en) * 2009-10-12 2010-04-14 北京科技大学 Process for preparing biocompatible directional carbon nanotube array reinforced composite hydrogel
CN102526806A (en) * 2012-01-20 2012-07-04 陕西博鸿生物科技有限公司 Tissue engineering cartilage and preparation method thereof
CN103007357A (en) * 2012-12-25 2013-04-03 福建省博特生物科技有限公司 Application of carbon nano tube/collagen based composite material
CN103013140A (en) * 2012-12-25 2013-04-03 福建省博特生物科技有限公司 Carbon nano tube/collagen based composite material and preparation method thereof
US9737632B2 (en) * 2013-09-25 2017-08-22 Nanofiber Solutions, Inc. Fiber scaffolds for use creating implantable structures

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
丁云: "功能化单壁碳纳米管与人血浆蛋白质相互作用的机制研究", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112778572A (en) * 2021-01-04 2021-05-11 常州大学 Collagen-based material capable of inhibiting new blood vessels and preparation method thereof
CN113244458A (en) * 2021-05-08 2021-08-13 康膝生物医疗(深圳)有限公司 Composite material for repairing articular cartilage damage and preparation method thereof
CN113244458B (en) * 2021-05-08 2022-07-08 康膝生物医疗(深圳)有限公司 Composite material for repairing articular cartilage damage and preparation method thereof

Similar Documents

Publication Publication Date Title
CN108653809B (en) Composite hydrogel based on black phosphorus and gelatin and application of composite hydrogel in bone tissue engineering
Yan et al. Injectable in situ forming poly (l-glutamic acid) hydrogels for cartilage tissue engineering
Yang et al. Bioinspired poly (γ-glutamic acid) hydrogels for enhanced chondrogenesis of bone marrow-derived mesenchymal stem cells
CN111184917B (en) Temperature-sensitive collagen-based hydrogel loaded with bioactive polypeptide and preparation method thereof
He et al. Gelatin methacryloyl hydrogel, from standardization, performance, to biomedical application
CN110818921B (en) Rapidly-curable double-crosslinked hydrogel and preparation method and application thereof
CN112126080B (en) Photocuring hydrogel based on sulfydryl-alkene click reaction, and preparation method and application thereof
Ko et al. Reinforced gelatin-methacrylate hydrogels containing poly (lactic-co-glycolic acid) nanofiber fragments for 3D bioprinting
CN103127548A (en) Manufacture method of artificial nerve conduit for promoting nerve defect repair
CN111135344A (en) Scaffold for repairing carbon nano tube/collagen-based cartilage of composite albumin and preparation method thereof
CN112494463B (en) Berberine/mineralized collagen composite membrane as well as preparation method and application thereof
CN104587531B (en) A kind of preparation method of gel stent of repairing articular cartilage damage
CN108310463B (en) 3D printing biological ink and preparation method thereof
CN112972760A (en) Endothelial extracellular matrix-loaded 3D printing bone defect repair stent and preparation method thereof
Dai et al. Improved thermostability and cytocompatibility of bacterial cellulose/collagen composite by collagen fibrillogenesis
Vigneswari et al. Elucidating the surface functionality of biomimetic rgd peptides immobilized on nano-p (3hb-co-4hb) for h9c2 myoblast cell proliferation
CN106668950A (en) Fibroin three-dimensional bracket for nervus centralis remediation
CN113150561A (en) Collagen-based biological ink for 3D biological printing and preparation method and application thereof
CN102133432A (en) Preparation method of silk fibroin micropore bracket
CN108452378B (en) 3D biological printing forming method
CN112646202B (en) Functionalized double-network hydrogel and preparation method and application thereof
CN111235662B (en) Collagen long fiber with natural structure and preparation method and application thereof
CN114887116A (en) Mesenchymal stem cell extracellular matrix-loaded 3D printing bone defect repair support and preparation method thereof
CN108904890B (en) Dynamic electrostatic deposition compound natural material bionic porous microcarrier and preparation method thereof
JP6143163B2 (en) Method for producing elastic tissue-like structure

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200512